Dublin, Dec. 14, 2021 (GLOBE NEWSWIRE) -- The "Pharmaceutical Analytical Testing Outsourcing Market Research Report by Product Type, Service, End-users, Application, and Region - Global Forecast to 2026 - Cumulative Impact of COVID-19" report has been added to ResearchAndMarkets.com's offering.
The Global Pharmaceutical Analytical Testing Outsourcing Market size was estimated at USD 6,558.16 million in 2020, is expected to reach USD 7,143.15 million in 2021, and projected to grow at a CAGR of 9.25% reaching USD 11,156.08 million by 2026.
Market Statistics
The report provides market sizing and forecast across five major currencies - USD, EUR GBP, JPY, and AUD. It helps organization leaders make better decisions when currency exchange data is readily available. In this report, the years 2018 and 2019 are considered historical years, 2020 as the base year, 2021 as the estimated year, and years from 2022 to 2026 are considered the forecast period.
Market Segmentation & Coverage
This research report categorizes the Pharmaceutical Analytical Testing Outsourcing to forecast the revenues and analyze the trends in each of the following sub-markets:
- Based on Product Type, the market was studied across Active Pharmaceutical Ingredients, Additives, Finished Product, and Raw Materials.
- Based on Service, the market was studied across Bioanalytical Testing, Method Development & Validation, and Stability Testing. The Bioanalytical Testing is further studied across Clinical and Non-Clinical. The Method Development & Validation is further studied across Extractable & Leachable, Impurity Method, and Technical Consulting. The Stability Testing is further studied across Accelerated Stability Testing, Drug Substance, Photostability Testing, and Stability Indicating Method Validation.
- Based on End-users, the market was studied across Biopharmaceuticals, Contract Manufacturing organizations, Others, and Pharmaceuticals.
- Based on Application, the market was studied across Bio Analytical Testing, Method Development & Validation, Others, and Stability Testing.
- Based on Region, the market was studied across Americas, Asia-Pacific, and Europe, Middle East & Africa. The Americas is further studied across Argentina, Brazil, Canada, Mexico, and United States. The United States is further studied across California, Florida, Illinois, New York, Ohio, Pennsylvania, and Texas. The Asia-Pacific is further studied across Australia, China, India, Indonesia, Japan, Malaysia, Philippines, Singapore, South Korea, Taiwan, and Thailand. The Europe, Middle East & Africa is further studied across France, Germany, Italy, Netherlands, Qatar, Russia, Saudi Arabia, South Africa, Spain, United Arab Emirates, and United Kingdom.
Competitive Strategic Window
The Competitive Strategic Window analyses the competitive landscape in terms of markets, applications, and geographies to help the vendor define an alignment or fit between their capabilities and opportunities for future growth prospects. It describes the optimal or favorable fit for the vendors to adopt successive merger and acquisition strategies, geography expansion, research & development, and new product introduction strategies to execute further business expansion and growth during a forecast period.
FPNV Positioning Matrix
The FPNV Positioning Matrix evaluates and categorizes the vendors in the Pharmaceutical Analytical Testing Outsourcing Market based on Business Strategy (Business Growth, Industry Coverage, Financial Viability, and Channel Support) and Product Satisfaction (Value for Money, Ease of Use, Product Features, and Customer Support) that aids businesses in better decision making and understanding the competitive landscape.
Market Share Analysis
The Market Share Analysis offers the analysis of vendors considering their contribution to the overall market. It provides the idea of its revenue generation into the overall market compared to other vendors in the space. It provides insights into how vendors are performing in terms of revenue generation and customer base compared to others. Knowing market share offers an idea of the size and competitiveness of the vendors for the base year. It reveals the market characteristics in terms of accumulation, fragmentation, dominance, and amalgamation traits.
Company Usability Profiles
The report profoundly explores the recent significant developments by the leading vendors and innovation profiles in the Global Pharmaceutical Analytical Testing Outsourcing Market, including Ajinomoto Bio-Pharma, Alcami Corporation, AptarGroup, Inc., Aztech Sciences Inc., Boston Analytical, Inc., Cambrex Corporation, Catalent, Inc, Charles River Laboratories International, Inc., Eurofins Scientific, Exova Group PLC, Intertek Group PLC, Merck KGaA, Pace Analytical Services, Inc., Pharmaceutical Product Development, LLC, Recro Gainesville, SEIKAGAKU CORPORATION, SGS SA, Source BioScience, Toxikon, Inc., West Pharmaceutical Services Inc., and WuXi AppTec, Inc.
The report provides insights on the following pointers:
1. Market Penetration: Provides comprehensive information on the market offered by the key players
2. Market Development: Provides in-depth information about lucrative emerging markets and analyze penetration across mature segments of the markets
3. Market Diversification: Provides detailed information about new product launches, untapped geographies, recent developments, and investments
4. Competitive Assessment & Intelligence: Provides an exhaustive assessment of market shares, strategies, products, certification, regulatory approvals, patent landscape, and manufacturing capabilities of the leading players
5. Product Development & Innovation: Provides intelligent insights on future technologies, R&D activities, and breakthrough product developments
The report answers questions such as:
1. What is the market size and forecast of the Global Pharmaceutical Analytical Testing Outsourcing Market?
2. What are the inhibiting factors and impact of COVID-19 shaping the Global Pharmaceutical Analytical Testing Outsourcing Market during the forecast period?
3. Which are the products/segments/applications/areas to invest in over the forecast period in the Global Pharmaceutical Analytical Testing Outsourcing Market?
4. What is the competitive strategic window for opportunities in the Global Pharmaceutical Analytical Testing Outsourcing Market?
5. What are the technology trends and regulatory frameworks in the Global Pharmaceutical Analytical Testing Outsourcing Market?
6. What is the market share of the leading vendors in the Global Pharmaceutical Analytical Testing Outsourcing Market?
7. What modes and strategic moves are considered suitable for entering the Global Pharmaceutical Analytical Testing Outsourcing Market?
Key Topics Covered:
1. Preface
2. Research Methodology
3. Executive Summary
4. Market Overview
4.1. Introduction
4.2. Cumulative Impact of COVID-19
5. Market Dynamics
5.1. Introduction
5.2. Drivers
5.2.1. Growing research and development in drug discovery and development
5.2.2. Rising incidence of cancer and other infectious diseases worldwide
5.2.3. Increasing innovation in the pharmaceutical industry
5.3. Restraints
5.3.1. Relatively high cost involved in drug development
5.4. Opportunities
5.4.1. Emerging technological advancements in testing procedures for drug development
5.4.2. Growing demand of regulatory bodies for analytical details on drugs
5.5. Challenges
5.5.1. Lack of consistency in the product quality
6. Pharmaceutical Analytical Testing Outsourcing Market, by Product Type
6.1. Introduction
6.2. Active Pharmaceutical Ingredients
6.3. Additives
6.4. Finished Product
6.5. Raw Materials
7. Pharmaceutical Analytical Testing Outsourcing Market, by Service
7.1. Introduction
7.2. Bioanalytical Testing
7.2.1. Clinical
7.2.2. Non-Clinical
7.3. Method Development & Validation
7.3.1. Extractable & Leachable
7.3.2. Impurity Method
7.3.3. Technical Consulting
7.4. Stability Testing
7.4.1. Accelerated Stability Testing
7.4.2. Drug Substance
7.4.3. Photostability Testing
7.4.4. Stability Indicating Method Validation
8. Pharmaceutical Analytical Testing Outsourcing Market, by End-users
8.1. Introduction
8.2. Biopharmaceuticals
8.3. Contract Manufacturing organizations
8.4. Others
8.5. Pharmaceuticals
9. Pharmaceutical Analytical Testing Outsourcing Market, by Application
9.1. Introduction
9.2. Bio Analytical Testing
9.3. Method Development & Validation
9.4. Others
9.5. Stability Testing
10. Americas Pharmaceutical Analytical Testing Outsourcing Market
10.1. Introduction
10.2. Argentina
10.3. Brazil
10.4. Canada
10.5. Mexico
10.6. United States
11. Asia-Pacific Pharmaceutical Analytical Testing Outsourcing Market
11.1. Introduction
11.2. Australia
11.3. China
11.4. India
11.5. Indonesia
11.6. Japan
11.7. Malaysia
11.8. Philippines
11.9. Singapore
11.10. South Korea
11.11. Taiwan
11.12. Thailand
12. Europe, Middle East & Africa Pharmaceutical Analytical Testing Outsourcing Market
12.1. Introduction
12.2. France
12.3. Germany
12.4. Italy
12.5. Netherlands
12.6. Qatar
12.7. Russia
12.8. Saudi Arabia
12.9. South Africa
12.10. Spain
12.11. United Arab Emirates
12.12. United Kingdom
13. Competitive Landscape
13.1. FPNV Positioning Matrix
13.1.1. Quadrants
13.1.2. Business Strategy
13.1.3. Product Satisfaction
13.2. Market Ranking Analysis
13.3. Market Share Analysis, by Key Player
13.4. Competitive Scenario
13.4.1. Merger & Acquisition
13.4.2. Agreement, Collaboration, & Partnership
13.4.3. New Product Launch & Enhancement
13.4.4. Investment & Funding
13.4.5. Award, Recognition, & Expansion
14. Company Usability Profiles
14.1. Ajinomoto Bio-Pharma
14.2. Alcami Corporation
14.3. AptarGroup, Inc.
14.4. Aztech Sciences Inc.
14.5. Boston Analytical, Inc.
14.6. Cambrex Corporation
14.7. Catalent, Inc.
14.8. Charles River Laboratories International, Inc.
14.9. Eurofins Scientific
14.10. Exova Group PLC
14.11. Intertek Group PLC
14.12. Merck KGaA
14.13. Pace Analytical Services, Inc.
14.14. Pharmaceutical Product Development, LLC
14.15. Recro Gainesville
14.16. SEIKAGAKU CORPORATION
14.17. SGS SA
14.18. Source BioScience
14.19. Toxikon, Inc.
14.20. West Pharmaceutical Services Inc.
14.21. WuXi AppTec, Inc.
15. Appendix
For more information about this report visit https://www.researchandmarkets.com/r/738lxy
